Surgical Innovations(GB:SUN)
GBXÂ 0.550.00 (0.00%)
GB:SUN
Surgical Innovations financials statements
GBXÂ 0.55
At close:0.00 (0.00%)
Want to see GB:SUN full AI Analyst Report?
Surgical Innovations (SUN) Ratios
8 Followers
Surgical Innovations Ratios
GB:SUN's free cash flow for Q2 2026 was £196.00K. For the 2026 fiscal year, GB:SUN's free cash flow was decreased by £-4.00K and operating cash flow was £200.00K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.48 | 1.88 | 2.32 | 2.54 | 2.01 |
| Quick Ratio | 0.85 | 0.83 | 1.23 | 1.46 | 1.29 |
| Cash Ratio | 0.24 | 0.07 | 0.46 | 0.75 | 0.88 |
| Solvency Ratio | -0.06 | -0.02 | 0.06 | 0.18 | 0.05 |
| Operating Cash Flow Ratio | 0.17 | -0.03 | 0.15 | 0.17 | -0.10 |
| Short-Term Operating Cash Flow Coverage | 3.79 | -0.21 | 1.14 | 1.27 | -0.23 |
| Net Current Asset Value | £ 1.10M | £ 1.62M | £ 2.25M | £ 2.78M | £ 3.25M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.06 | 0.10 | 0.12 | 0.14 | 0.18 |
| Debt-to-Equity Ratio | 0.09 | 0.15 | 0.16 | 0.20 | 0.26 |
| Debt-to-Capital Ratio | 0.08 | 0.13 | 0.14 | 0.16 | 0.21 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.02 | 0.05 | 0.07 | 0.00 |
| Financial Leverage Ratio | 1.52 | 1.43 | 1.37 | 1.42 | 1.47 |
| Debt Service Coverage Ratio | -0.11 | 0.02 | 0.79 | 1.98 | 0.19 |
| Interest Coverage Ratio | -11.08 | -7.99 | -4.52 | 0.42 | -3.69 |
| Debt to Market Cap | 0.04 | 0.10 | 0.15 | 0.08 | 0.09 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 2.03 | -10.56 | 2.80 | -0.06 | -3.47 |
| Profitability Margins | |||||
| Gross Profit Margin | 26.31% | 28.77% | 28.70% | 34.59% | 34.31% |
| EBIT Margin | -6.30% | -16.33% | -4.96% | 0.36% | -4.99% |
| EBITDA Margin | -0.63% | -0.83% | 1.34% | 5.54% | 2.71% |
| Operating Profit Margin | -6.30% | -6.62% | -4.96% | 0.36% | -5.26% |
| Pretax Profit Margin | -8.14% | -17.16% | -6.06% | -0.50% | -6.41% |
| Net Profit Margin | -7.71% | -16.27% | -4.24% | 2.33% | -5.00% |
| Continuous Operations Profit Margin | -7.71% | -16.27% | -4.24% | 2.33% | -5.00% |
| Net Income Per EBT | 94.81% | 94.78% | 69.92% | -463.16% | 77.95% |
| EBT Per EBIT | 129.14% | 259.17% | 122.15% | -139.02% | 121.88% |
| Return on Assets (ROA) | -7.69% | -15.88% | -3.55% | 1.69% | -2.90% |
| Return on Equity (ROE) | -11.71% | -22.75% | -4.86% | 2.41% | -4.28% |
| Return on Capital Employed (ROCE) | -8.91% | -8.41% | -5.09% | 0.32% | -4.15% |
| Return on Invested Capital (ROIC) | -8.08% | -7.54% | -3.38% | -1.43% | -2.75% |
| Return on Tangible Assets | -14.39% | -28.51% | -6.53% | 2.87% | -4.80% |
| Earnings Yield | -21.32% | -37.87% | -9.09% | 1.77% | -2.07% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.61 | 6.39 | 7.54 | 0.00 | 0.00 |
| Payables Turnover | 6.04 | 7.48 | 7.33 | 5.22 | 5.50 |
| Inventory Turnover | 3.90 | 2.87 | 3.00 | 2.35 | 2.02 |
| Fixed Asset Turnover | 10.34 | 7.99 | 7.06 | 6.39 | 7.62 |
| Asset Turnover | 1.00 | 0.98 | 0.84 | 0.73 | 0.58 |
| Working Capital Turnover Ratio | 5.60 | 4.01 | 3.02 | 2.62 | 1.72 |
| Cash Conversion Cycle | 88.36 | 135.73 | 120.23 | 85.71 | 114.16 |
| Days of Sales Outstanding | 55.18 | 57.14 | 48.43 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 93.63 | 127.36 | 121.61 | 155.59 | 180.52 |
| Days of Payables Outstanding | 60.46 | 48.77 | 49.81 | 69.87 | 66.36 |
| Operating Cycle | 148.81 | 184.50 | 170.04 | 155.59 | 180.52 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.00 | -0.00 | 0.00 | 0.00 | -0.00 |
| Free Cash Flow Per Share | 0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Dividend Paid and CapEx Coverage Ratio | 9.33 | -0.22 | 0.58 | 0.45 | -0.66 |
| Capital Expenditure Coverage Ratio | 9.33 | -0.22 | 0.58 | 0.45 | -0.66 |
| Operating Cash Flow Coverage Ratio | 0.86 | -0.06 | 0.24 | 0.22 | -0.16 |
| Operating Cash Flow to Sales Ratio | 0.05 | -0.01 | 0.03 | 0.04 | -0.05 |
| Free Cash Flow Yield | 12.10% | -7.97% | -5.15% | -3.97% | -4.95% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -4.50 | -2.62 | -11.00 | 56.53 | -48.27 |
| Price-to-Sales (P/S) Ratio | 0.36 | 0.43 | 0.47 | 1.32 | 2.41 |
| Price-to-Book (P/B) Ratio | 0.55 | 0.60 | 0.53 | 1.36 | 2.06 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 8.26 | -12.54 | -19.43 | -25.21 | -20.19 |
| Price-to-Operating Cash Flow Ratio | 7.38 | -69.33 | 13.99 | 30.71 | -50.83 |
| Price-to-Earnings Growth (PEG) Ratio | 0.09 | -0.01 | 0.04 | -0.35 | 0.55 |
| Enterprise Value Multiple | -55.47 | -62.38 | 37.56 | 23.71 | 85.64 |
| Enterprise Value | 4.05M | 6.18M | 6.05M | 14.89M | 21.15M |
| EV to EBITDA | -55.47 | -62.38 | 37.56 | 23.71 | 85.64 |
| EV to Sales | 0.35 | 0.52 | 0.50 | 1.31 | 2.32 |
| EV to Free Cash Flow | 7.97 | -15.10 | -21.00 | -25.15 | -19.41 |
| EV to Operating Cash Flow | 7.12 | -83.45 | 15.12 | 30.63 | -48.85 |
| Tangible Book Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Shareholders’ Equity Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.05 | 0.05 | 0.30 | 5.63 | 0.22 |
| Revenue Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Net Income Per Share | -0.00 | -0.00 | -0.00 | 0.00 | -0.00 |
| Tax Burden | 0.95 | 0.95 | 0.70 | -4.63 | 0.78 |
| Interest Burden | 1.29 | 1.05 | 1.22 | -1.39 | 1.29 |
| Research & Development to Revenue | 0.00 | 0.10 | 0.09 | 0.10 | 0.11 |
| SG&A to Revenue | 0.33 | 0.23 | 0.07 | 0.07 | 0.09 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -0.64 | 0.04 | -0.79 | 1.84 | 0.95 |
Currency in GBP
